What preoperative clearance and work‑up are recommended for a 38‑year‑old obese male with hypogonadism undergoing femoroacetabular impingement (FAI) repair?

Preoperative Clearance for 38-Year-Old Obese Male with Hypogonadism Undergoing FAI Repair

This patient requires cardiovascular risk assessment focused on obesity-related comorbidities, sleep-disordered breathing evaluation, and VTE risk stratification, with experienced surgical/anesthesia teams managing the case.

Cardiovascular Evaluation

The American Heart Association guidelines specifically address preoperative evaluation of obese surgical patients 1. For this 38-year-old obese male, focus on:

• Atherosclerotic cardiovascular disease screening - obesity increases risk even at younger ages
• Heart failure assessment - physical exam and ECG often underestimate cardiac dysfunction in obesity
• Systemic hypertension evaluation - highly prevalent in obese patients
• Pulmonary hypertension screening - related to sleep apnea and hypoventilation

The physical examination and ECG frequently underestimate cardiac dysfunction in obese patients 1, so maintain a high index of suspicion even with normal findings.

Critical Obesity-Specific Assessments

Sleep-Disordered Breathing

Sleep-disordered breathing and its consequences must always be considered in obese patients 2. This is non-negotiable given the rapid desaturation risk during anesthesia and increased postoperative respiratory complications. Screen for:

• Witnessed apneas
• Excessive daytime somnolence
• Morning headaches
• Documented obstructive sleep apnea

If present or suspected, plan for extended postoperative monitoring and potential level-2 care 2.

Central Obesity and Metabolic Syndrome

Central obesity and metabolic syndrome should be identified as specific risk factors 2. Unlike peripheral fat distribution, visceral fat is metabolically active and increases perioperative risk 2. Assess for metabolic syndrome components beyond just BMI.

Hypogonadism Considerations

While the guidelines don't specifically address hypogonadism in this surgical context, evaluate:

• Current testosterone replacement therapy (affects thrombotic risk)
• Associated cardiovascular effects
• Bone density concerns (relevant for orthopedic surgery)

FAI-Specific Preoperative Factors

Recent evidence identifies obesity as a significant prognostic factor for FAI surgery outcomes 3, 4. Obese patients have:

• >2-fold increased odds of conversion to total hip arthroplasty 3
• Significantly worse THA-free survivorship (80.4% vs 96.4% in normal-weight patients) 4
• Lower baseline functional scores but similar magnitude of improvement 3

Counsel this patient explicitly about increased conversion to arthroplasty risk - this directly impacts informed consent and surgical decision-making.

Required Preoperative Work-Up

Laboratory/Diagnostic Testing

• ECG - mandatory but recognize its limitations in obesity 1
• Consider echocardiography if cardiac symptoms present (dyspnea, edema are common but nonspecific in obesity) 1
• Basic metabolic panel
• Consider sleep study if sleep-disordered breathing suspected

Imaging

Standard FAI imaging includes radiographs and MRI 5, 6. Avoid routine preoperative CT - recent data shows CT before FAI surgery associates with increased long-term malignancy risk (OR 1.33), blood dyscrasias (OR 1.78), and endocrine disorders (OR 1.47) 7. Reserve CT only for complex surgical planning when absolutely necessary.

Anesthesia Planning Requirements

Experienced anesthetic and surgical staff must manage obese patients 2. Ensure:

• Specialized equipment availability (appropriate-sized OR table, positioning aids)
• Robust airway strategy planned - desaturation occurs rapidly 2
• Ramped or sitting position for induction/recovery 2
• Drug dosing based on lean body weight, titrated to effect 2

VTE Prophylaxis

All obese patients undergoing orthopedic surgery require VTE prophylaxis 2. For this patient:

• Pharmacologic prophylaxis is mandatory - BMI >30 kg/m² is an independent indication 2
• Orthopedic surgery with theatre time >90 minutes qualifies 2
• Use weight-adjusted LMWH dosing (if 100-150 kg: enoxaparin 40mg twice daily) 2
• Plan early mobilization - patient should be out of bed day of surgery 2

Postoperative Planning

Consider postoperative level-2 care, determined by comorbidities rather than obesity alone 2. Specific indications include:

• Documented or suspected sleep-disordered breathing
• Significant cardiovascular comorbidities
• Need for patient-controlled analgesia (increased respiratory depression risk) 2

Extended PACU monitoring is required until respiratory rate normalizes with no apnea/hypopnea episodes for ≥1 hour and oxygen saturation returns to baseline 2.

Common Pitfalls to Avoid

• Don't rely solely on physical exam and ECG - they underestimate cardiac dysfunction in obesity 1
• Don't assume young age eliminates cardiovascular risk - obesity-related comorbidities occur across age groups
• Don't use total body weight for drug dosing - base on lean body weight 2
• Don't discharge from PACU without observing unstimulated breathing - watch for hypoventilation episodes 2
• Don't underestimate VTE risk - this patient has multiple risk factors (obesity, orthopedic surgery, male sex, potential immobility)